Avantax Advisory Services Inc. Has $3.47 Million Stock Position in Stryker Co. (NYSE:SYK)

Avantax Advisory Services Inc. lowered its stake in Stryker Co. (NYSE:SYK) by 1.9% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 9,701 shares of the medical technology company’s stock after selling 183 shares during the quarter. Avantax Advisory Services Inc.’s holdings in Stryker were worth $3,472,000 at the end of the most recent reporting period.

A number of other large investors also recently made changes to their positions in SYK. Burkett Financial Services LLC bought a new stake in shares of Stryker in the 4th quarter valued at $25,000. Farmers & Merchants Trust Co of Chambersburg PA increased its position in shares of Stryker by 203.3% in the 4th quarter. Farmers & Merchants Trust Co of Chambersburg PA now owns 91 shares of the medical technology company’s stock valued at $27,000 after buying an additional 61 shares in the last quarter. Rogco LP bought a new stake in shares of Stryker in the 4th quarter valued at $30,000. DSM Capital Partners LLC bought a new stake in shares of Stryker in the 4th quarter valued at $34,000. Finally, HBC Financial Services PLLC bought a new stake in shares of Stryker in the 4th quarter valued at $37,000. Institutional investors and hedge funds own 77.09% of the company’s stock.

Analysts Set New Price Targets

SYK has been the subject of a number of research reports. Wells Fargo & Company increased their target price on Stryker from $364.00 to $381.00 and gave the stock an “overweight” rating in a report on Wednesday, May 1st. TD Cowen raised their price objective on Stryker from $365.00 to $400.00 and gave the company a “buy” rating in a report on Thursday, April 11th. Morgan Stanley raised their price objective on Stryker from $345.00 to $350.00 and gave the company an “equal weight” rating in a report on Monday. Barclays raised their price objective on Stryker from $372.00 to $376.00 and gave the company an “overweight” rating in a report on Thursday, May 2nd. Finally, Roth Mkm raised their price objective on Stryker from $348.00 to $405.00 and gave the company a “buy” rating in a report on Wednesday, May 1st. Four equities research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $372.05.

Stryker Price Performance

NYSE:SYK traded up $4.86 during mid-day trading on Tuesday, reaching $333.42. The stock had a trading volume of 1,336,429 shares, compared to its average volume of 1,279,944. The stock has a 50-day simple moving average of $337.96 and a two-hundred day simple moving average of $336.99. The stock has a market capitalization of $127.02 billion, a PE ratio of 37.51, a P/E/G ratio of 2.67 and a beta of 0.89. The company has a debt-to-equity ratio of 0.56, a current ratio of 1.71 and a quick ratio of 0.99. Stryker Co. has a 12 month low of $249.98 and a 12 month high of $361.41.

Stryker (NYSE:SYK) last announced its quarterly earnings data on Tuesday, April 30th. The medical technology company reported $2.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.36 by $0.14. The business had revenue of $5.24 billion for the quarter, compared to analysts’ expectations of $5.10 billion. Stryker had a net margin of 16.03% and a return on equity of 23.05%. The firm’s quarterly revenue was up 9.7% compared to the same quarter last year. During the same period last year, the firm posted $2.14 earnings per share. On average, equities analysts anticipate that Stryker Co. will post 11.95 earnings per share for the current year.

Stryker Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, July 31st. Stockholders of record on Friday, June 28th will be issued a dividend of $0.80 per share. The ex-dividend date of this dividend is Friday, June 28th. This represents a $3.20 dividend on an annualized basis and a dividend yield of 0.96%. Stryker’s dividend payout ratio (DPR) is presently 36.53%.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.